Compounds > triethylenemelamine
Page last updated: 2024-11-06

triethylenemelamine and Epistaxis

triethylenemelamine has been researched along with Epistaxis in 2 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Epistaxis: Bleeding from the nose.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HECK, WE1
MCNAUGHT, RC1
SPAET, TH1
DRAGANESCU, CI1
GOGA-IONESCU, S1
CSAP, CF1
COPORAN, R1

Other Studies

2 other studies available for triethylenemelamine and Epistaxis

ArticleYear
Epistaxis due to thrombocythemia; report of an unusual case.
    Transactions of the Pacific Coast Oto-Ophthalmological Society annual meeting, 1955, Volume: 36

    Topics: Blood Platelets; Epistaxis; Thrombocytosis; Triethylenemelamine

1955
[RESULTS OBTAINED IN TWO CASES OF SEVERE LEUKOTHROMBOPENIA WITH A HEMORRHAGIPAROUS SYNDROME, APPEARING AFTER ADMINISTRATION OF CYTOSTATICS, TREATED WITH HOMOLOGOUS HEMATOPOIETIC TISSUE].
    Medicina interna, 1963, Volume: 15

    Topics: Antineoplastic Agents; Bone Marrow Transplantation; Breast Neoplasms; Cytostatic Agents; Ecchymosis;

1963